We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 17.11% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Financials | 8% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Milestone Pharmaceuticals
MIST
$157M
| $476K | ﹤0.01% |
167,101
-65,391
| -28% | -$247K |
|
1977
PUT
iShares MSCI South Korea ETF
EWY
$25.8B
| $475K | ﹤0.01% |
+7,500
| New | +$470K |
|
|
TGH
1978
DELISTED
Textainer Group Holdings limited
TGH
| $474K | ﹤0.01% |
12,036
+5,153
| +75% | +$188K |
|
|
ITOS
1979
DELISTED
iTeos Therapeutics
ITOS
| $469K | ﹤0.01% |
35,429
-19,580
| -36% | -$279K |
|
1980
Fox Class B
FOX
$23.3B
| $466K | ﹤0.01% |
14,600
-237,346
| -94% | -$7.19M |
|
1981
Harmonic Inc
HLIT
$1.24B
| $464K | ﹤0.01% |
28,700
-397,999
| -93% | -$6.39M |
|
1982
Westrock Coffee
WEST
$800M
| $464K | ﹤0.01% |
42,685
-334
| -0.8% | -$3.87K |
|
1983
MacroGenics
MGNX
$250M
| $459K | ﹤0.01% |
85,829
-172,119
| -67% | -$1.06M |
|
1984
PepsiCo
PEP
$189B
| $458K | ﹤0.01% |
2,474
-352,821
| -99% | -$65.8M |
|
|
LGF.A
1985
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $458K | ﹤0.01% |
+51,890
| New | +$546K |
|
1986
Allison Transmission
ALSN
$10.3B
| $457K | ﹤0.01% |
+8,100
| New | +$398K |
|
1987
United Microelectronic
UMC
$47.5B
| $457K | ﹤0.01% |
+57,900
| New | +$477K |
|
1988
MaxLinear
MXL
$6.24B
| $454K | ﹤0.01% |
+14,400
| New | +$416K |
|
1989
Bausch Health
BHC
$2.33B
| $453K | ﹤0.01% |
56,586
-70,789
| -56% | -$522K |
|
1990
Aquestive Therapeutics
AQST
$552M
| $449K | ﹤0.01% |
+272,395
| New | +$493K |
|
1991
Sun Life Financial
SLF
$44.7B
| $448K | ﹤0.01% |
+8,600
| New | +$423K |
|
|
SPWR
1992
DELISTED
SunPower Corporation Common Stock
SPWR
| $448K | ﹤0.01% |
45,734
-685,625
| -94% | -$8M |
|
1993
Valens Semiconductor
VLN
$183M
| $443K | ﹤0.01% |
175,240
-93,610
| -35% | -$238K |
|
|
ESPR
1994
DELISTED
Esperion Therapeutics
ESPR
| $439K | ﹤0.01% |
315,929
+28,324
| +10% | +$39.5K |
|
1995
CALL
Moderna
MRNA
$24.3B
| $437K | ﹤0.01% |
3,600
-31,300
| -90% | -$4.18M |
|
|
SBR
1996
Sabine Royalty Trust
SBR
$1.06B
| $437K | ﹤0.01% |
+6,623
| New | +$474K |
|
1997
WhiteHorse Finance
WHF
$153M
| $436K | ﹤0.01% |
+33,966
| New | +$414K |
|
1998
Cosan
CSAN
$2.54B
| $435K | ﹤0.01% |
+29,165
| New | +$379K |
|
1999
Avita Medical
RCEL
$252M
| $434K | ﹤0.01% |
25,500
-36,215
| -59% | -$531K |
|
|
LSEA
2000
DELISTED
Landsea Homes
LSEA
| $433K | ﹤0.01% |
+46,400
| New | +$325K |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.